scispace - formally typeset
D

David N. Brindley

Researcher at University of Alberta

Publications -  254
Citations -  12951

David N. Brindley is an academic researcher from University of Alberta. The author has contributed to research in topics: Phosphatidate & Phosphatidate phosphatase. The author has an hindex of 65, co-authored 248 publications receiving 12403 citations. Previous affiliations of David N. Brindley include University of Nottingham.

Papers
More filters
Journal ArticleDOI

Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns

TL;DR: The results establish the three mammalian lipin proteins as PAP1 enzymes and explain the biochemical basis for lipodystrophy in the lipin-1-deficient fld mouse.
Journal ArticleDOI

High-fat feeding alters both basal and stress-induced hypothalamic-pituitary-adrenal activity in the rat

TL;DR: Dietary fat intake acts as a background form of chronic stress, elevating basal B levels and enhancing HPA responses to stress, suggesting support for the specificity of the effects on the HPA axis.
Journal ArticleDOI

Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis.

TL;DR: Sphingosine 1‐phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis.
Journal ArticleDOI

(n-3) PUFA Alter Raft Lipid Composition and Decrease Epidermal Growth Factor Receptor Levels in Lipid Rafts of Human Breast Cancer Cells

TL;DR: The results indicate that (n-3) FA modify the lipid composition of membrane rafts and alter EGFR signaling in a way that decreases the growth of breast tumors.
Journal ArticleDOI

Possible connections between stress, diabetes, obesity, hypertension and altered lipoprotein metabolism that may result in atherosclerosis.

TL;DR: Observations provide a partial explanation for the metabolic changes that can accompany the risk factors and clarify why they interact in promoting atherosclerosis.